Capital Chevrolet of Wake Forest Honors 2025 Wake County Teacher of the Year with New Vehicle
Brinson, who has been teaching for six years, the last four at Kingswood Magnet, was honored with the Teacher of the Year award for her unwavering commitment to her students and the community. She is known for crafting engaging lessons that cater to all learners, fostering a supportive environment, and advocating for students with special needs. Beyond the classroom, Brinson leads a running club, organizes the annual Walk to School Day, and supports the Special Olympics. Her efforts exemplify the values of dedication, inclusivity, and community engagement.
As part of the Teacher of the Year recognition, Brinson will participate in the Go Global NC international study program in Botswana and Zambia during summer 2026, sponsored by the Dan Royster Memorial Teacher Award. She will also attend the Global Leaders Teacher Fellowship conference, compliments of Participate Learning. Additionally, she received an engraved award, a $100 gift card to Angus Barn, a $1,000 check from sponsors, a weekend stay at the Umstead Hotel and Spa with complimentary breakfast at Heron's Restaurant, a $100 Amazon gift card, a Chromebook from Lenovo, and a gift bag from Crossroads Chick-fil-A.
Capital Chevrolet of Wake Forest has a long-standing tradition of supporting local educators and community initiatives. The dealership is honored to contribute to the recognition of outstanding educators like Brinson, who inspire and shape the future of our community.
For more information about Capital Chevrolet of Wake Forest and its community involvement, please visit https://www.capitalchevrolet.com/.
CONTACT:
Capital Chevrolet of Wake Forest
9820 Capital Blvd
Wake Forest, NC 27587
Phone: (919) 584-9680
Email: [email protected]
Website: www.capitalchevrolet.com
MULTIMEDIA:
LOGO link for media: https://www.Send2Press.com/300dpi/25-0501-s2p-capchevlf-300dpi.jpg
NEWS SOURCE: Capital Chevrolet
Keywords: Auto Dealer News, Capital Chevrolet of Wake Forest, Teacher of the Year, Kingswood Magnet Elementary, Go Global NC international study program, WAKE FOREST, N.C.
This press release was issued on behalf of the news source (Capital Chevrolet) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P125947 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/capital-chevrolet-of-wake-forest-honors-2025-wake-county-teacher-of-the-year-with-new-vehicle/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
42 minutes ago
- Business Wire
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
MINNEAPOLIS--(BUSINESS WIRE)-- HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private and public investors, including K5 Global, Bezos Expeditions, Wellington Management and other new and existing investors. The transaction values HistoSonics at approximately $2.25 billion and positions the company for accelerated growth of the Edison System across new clinical indications and global markets. HistoSonics will continue to be led by President and Chief Executive Officer, Mike Blue, and his executive team. Mr. Blue will also assume the role of Chairman of the Board upon closing. 'Our relentless focus as a company has been speed, scale, and the urgency to offer patients a better option than any they have today,' said Mr. Blue. 'This new group of partners backs category-defining companies that transform entire industries. Their support gives us the firepower to accelerate our momentum, expand into new clinical indications, and reach even more patients around the world who urgently need our breakthrough therapy.' HistoSonics plans to expand beyond its initial focus on liver tumors to kidney, pancreas, and prostate indications, with a long-term vision of histotripsy being used across a wide range of clinical applications throughout the body, treating both benign and malignant conditions. 'What stood out with HistoSonics wasn't just the technology, it was the speed and clarity with which the team turned a breakthrough into real clinical traction,' said Bryan Baum, Co-Founder and Managing Partner, K5 Global. 'Hospitals are continuing to order systems, patient demand is surging, and the clinical results speak for themselves. We partnered with HistoSonics because this is one of those rare moments where the science, the execution, and the opportunity all align, and we are here to ensure it reaches every hospital in the world.' HistoSonics, founded in 2009, received FDA De Novo clearance in October 2023 and uses non-invasive focused ultrasound energy to mechanically destroy and liquify targeted tissue and tumors at a sub-cellular level and without the invasiveness or toxicity of traditional procedures. To date, over 2,000 patients have been treated by the Edison system at over 50 leading U.S. medical centers, with another 50 planned system installations by year-end. Supported by extensive preclinical and clinical research across multiple organ systems, including liver, kidney, pancreas, prostate and others, the company is currently enrolling patients in clinical trials for liver tumors, kidney tumors (HOPE4KIDNEY Trial NCT05820087) and pancreas tumors (GANNON Trial NCT06282809), with plans to start others in the near future. Additional participants in the transaction include top‑tier global investment firms, including Alpha JWC Ventures, alongside existing investors Alpha Wave Ventures, Venture Investors Health Fund, Lumira Ventures, Hatteras Venture Partners, Early Stage Partners, Amzak Health, HealthQuest Capital, Yonjin Venture, the State of Wisconsin Investment Board, the State of Michigan Retirement System, Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson - JJDC, Inc. (JJDC), and others. Citi served as financial advisor and Fox Rothschild served as legal advisor to HistoSonics. Morgan Stanley & Co. LLC served as financial advisor and Cooley, with assistance from Orrick, served as legal advisors to the investment syndicate. Wilson Sonsini Goodrich & Rosati served as legal advisor to Histosonics' existing major shareholders. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, MI and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit:
Business Wire
42 minutes ago
- Business Wire
VIVOLTA and Fibrothelium partner to manufacture SimplySilk® membrane for Guided Bone Regeneration
WAALRE, Netherlands--(BUSINESS WIRE)--VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Fibrothelium, a specialist in silk protein biomaterials, to manufacture electrospun components for use in Fibrothelium's SimplySilk® membrane – an advanced electrospun silk membrane designed to support guided bone regeneration (GBR) in oral surgery. Under the agreement, VIVOLTA will serve as the exclusive contract manufacturer of SimplySilk® membrane electrospun components, leveraging its fully automated MediSpin™ technology to produce the electrospun membranes at commercial scale while ensuring consistent quality and regulatory compliance. SimplySilk® membrane is a resorbable barrier membrane intended to facilitate bone regrowth in dental implants, periodontal procedures and cranio-maxillo-facial surgery. Developed with Fibrothelium's proprietary silk fibroin technology, the membrane features a unique multi-layer design, ensuring prolonged barrier function when clinically needed. Two porous, fleece-like outer layers promote rapid soft tissue integration, while an optional compact silk fibroin film core slows biodegradation and enhances mechanical stability. Unlike conventional GBR membranes derived from animal collagen, SimplySilk® membrane is entirely free of animal tissue, eliminating the risk of pathogen transmission and supporting extended degradation profiles. Fibrothelium's biocompatible PureSilk® material promotes safe, predictable healing of bone defects. The membrane naturally resorbs over time, removing the need for patients to undergo a second surgery to remove it once the healing process is complete. Global demand for regenerative dental solutions is rising, fueled by growth in dental implant procedures and the increasing prevalence of periodontal disease. The GBR membrane market was estimated at roughly $520 million in 2024 and is forecast to nearly double to $950 million by 2033, growing at about 7.5% annually. This growth is driven by the need for advanced biomaterial membranes that improve clinical outcomes in implantology and oral surgery. 1 Studies indicate that over 50% of dental implant patients require some form of bone grafting or GBR to rebuild lost bone. 2 With implant procedures on the rise worldwide, clinicians are seeking high-performance barrier membranes that provide reliable regeneration of bone tissue while minimizing complications. SimplySilk® membrane's long-term barrier function and animal-tissue-free composition positions it as a timely innovation in this expanding market. 3 SimplySilk® membrane is a CE-marked Class III medical device and is commercially available in Europe. Ongoing clinical studies demonstrate excellent performance in routine clinical applications. In parallel with its MDR recertification, Fibrothelium is preparing for FDA submission, with U.S. market approval targeted for 2027. Denis Leissing, CEO of VIVOLTA, said: 'This partnership with Fibrothelium underscores VIVOLTA's ability to support innovators from concept through commercialization. We are excited to apply our electrospinning expertise and MediSpin™ manufacturing platform to scale up SimplySilk® membrane production. 'By combining Fibrothelium's groundbreaking silk biomaterial with our unique high-volume electrospinning capabilities, we will help bring this advanced GBR membrane to dental patients worldwide. Our team is proud to enable a new animal-tissue-free solution that can improve healing and outcomes in regenerative procedures.' Hans Leemhuis, CEO of Fibrothelium, commented: 'Partnering with VIVOLTA marks a key milestone in scaling the production and the global availability of our SimplySilk® membrane. Vivolta's proven know-how in electrospun medical products and its state-of-the-art MediSpin™ system give us great confidence in the quality, reproducibility and scalability of our product as we ramp up production. 'We look forward to delivering our SimplySilk® membrane to clinicians worldwide as a safe, effective new animal-tissue-free option for regenerative procedures that supports optimal tissue regeneration and patient care.' About VIVOLTA VIVOLTA is a fully integrated medical electrospinning solutions provider devoted to the development and high-volume manufacturing of electrospun medical products for its clients. Vivolta offers end-to-end services from material R&D and product development through clinical-scale and commercial manufacturing, using its proprietary MediSpin™ platform to produce nanofiber-based medical devices and components with high precision and unwavering quality. About Fibrothelium Fibrothelium GmbH (Aachen, Germany) is a biomedical company specializing in silk fibroin-based biomaterials for clinical use. A spin-off from RWTH Aachen University in 2017, Fibrothelium has core expertise in isolating and purifying highly biocompatible, bioresorbable fibroin proteins from natural silk without the use of toxic solvents. This fibroin solution is the backbone of a proprietary process to create advanced regenerative products, enabling the transformation of silk fibroin into various forms and functions. Fibrothelium's technology is used to develop and manufacture next-generation resorbable implants – including the SimplySilk® membrane – that support tissue repair and regeneration in a safe and sustainable way. Sources: Verified Market Reports – GBR Membrane Market Insights 2025. Cha HS, Kim JW, Hwang JH, Ahn KM. Frequency of bone graft in implant surgery. Maxillofac Plast Reconstr Surg. 2016 Mar 31;38(1):19.
Business Wire
42 minutes ago
- Business Wire
Mariner Finance Implements CreditBrowser® from Digital Matrix Systems to Optimize Consumer Dispute Resolution
PLANO, Texas--(BUSINESS WIRE)-- Digital Matrix Systems, Inc. (DMS) announced today that Mariner Finance, LLC ('Mariner Finance') has selected the company's CreditBrowser® solution. Baltimore-based Mariner Finance will leverage CreditBrowser to enhance its investigation of customer inquiries and to help ensure compliance with industry standards and laws for accurate credit reporting. 'At Mariner Finance, providing an outstanding customer experience is at the heart of everything we do,' said Kellye Mull, Vice President, Credit Reporting & Disputes at Mariner Finance. With physical locations in over half the states, Mariner Finance operates coast-to-coast, focusing on superior customer service. Quality of service is a priority that Mariner Finance strives to deliver, providing customers with creative and flexible lending options. With consumers and regulators increasingly focused on credit report accuracy and fair lending practices, efficient and standardized access to data is crucial. CreditBrowser ® provides a proprietary Subscriber Code report view that consolidates data from multiple credit bureaus, using intuitive headers and color coding to simplify the process and presentation of data. Mariner Finance will use the tool to help address customer inquiries with efficiency and accuracy while upholding its high standards of personalized customer service. 'At Mariner Finance, providing an outstanding customer experience is at the heart of everything we do,' said Kellye Mull, Vice President, Credit Reporting & Disputes at Mariner Finance. 'Integrating CreditBrowser® into our processes empowers us to resolve credit report inquiries more quickly and, in turn, builds stronger relationships with our customers.' 'Customers expect clarity, speed, and transparency when it comes to managing their credit,' said Carson York, senior vice president at DMS. 'We're proud to partner with Mariner Finance as they continue to set a high standard for delivering customer-centered lending experiences.' About Digital Matrix Systems, Inc. Founded in 1982, Digital Matrix Systems (DMS) enhances business performance for financial institutions and insurers through data-driven insights, advanced analytics, risk management tools, and compliance solutions. DMS empowers clients to leverage credit and alternative data to make critical business decisions with greater confidence and precision. With deep expertise and a comprehensive product suite, including analytics, data compliance solutions, credit policy testing, Metro 2® auditing, and dispute resolution support, DMS helps clients navigate an evolving data ecosystem and stay competitive. For more information, visit and follow DMS on LinkedIn. About Mariner Finance Since 1927, the Mariner Finance family of companies has provided individually tailored and convenient lending options to its customers, with the goal of pairing them with a personal loan that meets their immediate needs. Mariner Finance provides hard-working consumers responsible access to credit through respectful, compassionate, and efficient service. Our experienced team members take pride in finding options that are beneficial to each customer's specific needs and are ready to assist every customer. Superior customer service is the reason for our continued success and why our customers recognize us as the community's consumer finance company of choice.
